1 |
2-mercaptobenzothiazole
| 0件: | - | - | - | 1件: 212 212 |
2 |
Ascorbic acid
| 4件: Acidum ascorbicum Acidum ascorbicum; Ascorbic acid; Iron; Vitamin C | 1件: D00018
D00018
| - | - | 8件: 10 10, 97, 192, 206, 210, 211, 212, 298 |
3 |
Bosentan
| 2件: Bosentan Bosentan; Tracleer | 2件: D01227
D01227
,
D07538
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
4 |
Dexmedetomidine
| 4件: Dexdor Dexdor; DEXMEDETOMIDINA; DEXMEDETOMIDINE; DEXMEDETOMIDINE HYDROCHLORIDE | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
5 |
Liothyronine
| 4件: Liothyronine Liothyronine; Liothyronine sodium; Thyroid; Triiodothyronine | 2件: D01011
D01011
,
D08128
| 2件: THRA THRA, THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 4件: 13 13, 78, 210, 212 |
6 |
Liothyronine I-131
| 1件: Liothyronine I 131 Liothyronine I 131 | - | - | - | 2件: 210 210, 212 |
7 |
Sildenafil
| 6件: Mysildecard Mysildecard; Revatio; Sildenafil; Sildenafil citrate; SILDENAFILO; Viagra | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |